retatrutide effectiveness Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide, a new weight loss

SEMA, como tratamiento de la obesidad, ha mostrado efectos nefroprotectores con disminucin del 22% del objetivo renal compuesto en el estudio SELECT33 en pacientes sin diabetes, abogando por la utilidad de SEMA en el tratamiento del sndrome cardio-reno-metablico

It is also our most precious asset, making us who we are as humans

Pharmacy Update Effective June 23, 2026 Important News For Our Pharmacy Customers Effective June 26, 2026, Revival Animal Health is no longer filling veterinary prescriptions

In this episode, Elizabeth welcomes registered dietitian Melissa Mitri, who has spent nearly two decades helping clients achieve sustainable weight loss through evidence-based nutrition and lifestyle strategies

Tanning Sprays & Injections: A Fair Girls Dream or a Dermatology Nightmare

Plasticity of renal erythropoietin-producing cells governs fibrosis